Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.Our AI platform rapidly directs us to the best drug candidates. It knows biology, from disease biomarkers all the way down to the level of DNA, RNA and the molecular machinery of the cell. Everyone at Deep Genomics uses the platform to do their work, and everyone participates in improving the platform. That includes our geneticists, biologists, chemists, toxicologists, clinicians and drug developers.
Total Funding: $56.7 M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2014
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Deep Genomics
Statistical Geneticist
Toronto, Ontario
Senior Scientist - Bioinformatics & Biostatistics
Toronto, Ontario
Scientist – Machine Learning
Toronto, Ontario
Graduate Research Intern (Machine Learning)
Toronto, Ontario
Scientist – Molecular & Cellular Biology (Systems Neuroscience)
Toronto, Ontario
Deep Genomics - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups
Deep Genomics - Manage Profile
World's Most Promising AI Startups
World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals
Get Started